Rhythm Pharmaceuticals (RYTM) Investor Presentation - Slideshow

Rhythm Pharmaceuticals Targeting MC4R pathway and transforming the care of patients with rare genetic diseases of obesity April 2022 ® © Rhythm® Pharmaceuticals, Inc. All rights reserved. Forward Looking Statements 2 This presentation contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, and that involve risks and uncertainties, including without limitation statements regarding the potential, safety, efficacy, and regulatory and clinical prog ...